Gaetano Scifo
Siracusa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 17, 2022
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort.
Journal: Journal of viral hepatitis
Published: December 03, 2020
Real-world experience with obeticholic acid in patients with primary biliary cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: September 10, 2020
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
Journal: The American journal of gastroenterology
Published: July 31, 2020
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.
Journal: Drugs in context
Published: April 04, 2020
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
Journal: Scandinavian journal of gastroenterology
Published: October 01, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
Journal: The American journal of gastroenterology
Published: May 29, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Journal: Journal of hepatology
Published: August 14, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Journal: Gastroenterology
Published: October 05, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study.
Journal: Alimentary pharmacology & therapeutics
Published: April 24, 2017
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 24, 2016
Last Updated: 09/26/2026